Your location：Home >News center >Industry News
Industry News
01-302023
Current Therapies For Non-Small Cell Lung…
Here, we will introduce the current targeted drug therapies and immunotherapies therapies for NSCLC based on official information from the American Cancer Society.
01-292023
Bystander Effect of Antibody-drug Conjuga…
Summarizing the current preclinical and clinical evidence about bystander effect of ADCs in solid tumors.
01-132023
2022 FDA Approval & Potencial Blockbu…
FDA approved 37 novel drugs IN 2022, lets find the potencial blockbusters.
01-092023
Summary of 10 Approved COVID-19 Small Mol…
So far, the need for effective therapies for COVID-19 remains high. As peoples understanding of the structure, function and pathogenic processes of the novel coronavirus has improved, many sm…
12-292022
Semaglutide: A Star Product In The Field …
In this article, we will introduce this new star semaglutide in the hypoglycemic and weight loss field.
12-272022
Clinical Toxicity Of Antibody Drug Conjug…
Antibody-drug conjugates side effects should not be ignored.
sales@huatengusa.com
+86 0731 89916275